Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Mumps vaccine Stories

2012-09-18 02:27:19

BEIJING, Sept. 18, 2012 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading China-based vaccine manufacturer, announced today that it has received GMP certification from the China State Food and Drug Administration (SFDA) for the Company's dedicated mumps vaccine production plant at its Sinovac Dalian facility. The SFDA issued a public announcement on September 12, 2012, stating that the Good Manufacturing Practices (GMP) certification was issued to Sinovac with the certificate...

2010-05-13 16:00:00

BEIJING, May 13 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading China-based vaccine manufacturer, announced today its unaudited financial results for the three-month period ended March 31, 2010. First Quarter 2010 Financial Highlights (comparisons to First Quarter 2009) -- Sales for the first quarter decreased 32% to $4.4 million -- Operating loss for the first quarter was $865,000, compared to operating income of $646,000 -- Net loss...